Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Receivables: 2024

Historic Receivables for Gossamer Bio (GOSS) over the last 1 years, with Dec 2024 value amounting to $5.5 million.

  • Gossamer Bio's Receivables rose 44.18% to $9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.8 million, marking a year-over-year change of. This contributed to the annual value of $5.5 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Gossamer Bio reported Receivables of $5.5 million as of FY2024.
  • Gossamer Bio's Receivables' 5-year high stood at $5.5 million during FY2024, with a 5-year trough of $5.5 million in FY2024.
  • Over the past 1 years, Gossamer Bio's median Receivables value was $5.5 million (recorded in 2024), while the average stood at $5.5 million.